Vascular Therapies

Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees

Vascular Therapies is a biotechnology company operating in the pharmaceutical manufacturing sector, focused on improving vascular access outcomes for patients with kidney and vascular disease. The company is based in Cresskill, New Jersey (105 Union Avenue) and has a small team of 2 to 10 employees. It has developed Sirogen™, a proprietary sirolimus formulation for local, perivascular drug delivery to reduce surgical stenosis in blood vessels. Sirogen is currently undergoing clinical trials to evaluate its safety and effectiveness in improving vascular access outcomes for patients requiring an arteriovenous fistula for hemodialysis. The company maintains a website at vasculartx.com for information about its activities.

Sign up for free to view info

Email Format Employee directory